Physician profile
Aniroodh Tudi Reddy
NPI 1033749494
$9,848.65
in general payments reported to CMS, 2019-2025
8 companies · $9,776 in 2025
The $9,776 reported for 2025 was more than what 97% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.02 · 2022: $35.58 · 2024: $24.98 · 2025: $9,776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $7,500 · Travel and Lodging: $1,151 · Food and Beverage: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $7,500.00 |
| Travel and Lodging | $1,151.09 |
| Food and Beverage | $1,149.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,970.39 | 2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Boston Scientific Corporation | $1,450.48 | 2024-2025 | Wavewriter Alpha Prime 16, Intracept, Accolade Sr |
| Spr Therapeutics, INC | $183.23 | 2025 | Sprint Pns System |
| Mml US, INC. | $159.90 | 2025 | Reactiv8 |
| Bioventus LLC | $37.05 | 2025 | Stimrouter Implantable Kit |
| Neurelis, INC. | $19.70 | 2022 | |
| Aprecia Pharmaceuticals, LLC | $15.88 | 2022 | |
| Amgen INC. | $12.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aniroodh Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.